Folk J C, Packer A J, Weingeist T A, Howcroft M J
Ophthalmic Surg. 1986 May;17(5):299-306.
Healon was implanted into the vitreous cavity of 33 eyes at the conclusion of pars plana vitrectomy. In aphakic eyes, Healon diffused rapidly into the anterior chamber, reducing the length of effective tamponade posteriorly and causing marked elevations of intraocular pressure. In phakic diabetic eyes, Healon appeared to trap hemorrhage mechanically from bleeding fibrovascular stumps posteriorly. It may therefore reduce the risk of opacifying vitreous hemorrhage after vitrectomy in phakic eyes with active neovascularization.
在扁平部玻璃体切除术后，将Healon植入33只眼的玻璃体腔。在无晶状体眼中，Healon迅速扩散至前房，缩短了后方有效填塞的长度，并导致眼压显著升高。在有晶状体的糖尿病眼中，Healon似乎能机械性地阻止来自后方出血的纤维血管残端的出血。因此，它可能降低有活动性新生血管形成的有晶状体眼玻璃体切除术后玻璃体出血混浊的风险。
